Julie Margenthaler’s practice centers on treating young women with breast cancer, who are more likely to be African-American and to have aggressive disease. “These women are empowered, and they bring a great energy to my practice,” Margenthaler, MD, says. “Yes, there are times when they are frightened — you have to face your mortality when you get a breast cancer diagnosis — but they also have an incredible optimism.”
A nationwide study has confirmed the benefit of giving estrogen-lowering drugs before surgery to breast cancer patients. The treatment increased the likelihood that women could undergo breast-conservation surgery, also called lumpectomy, instead of mastectomy.